Cookson Peirce & Co’s Surmodics SRDX Stock Holding History

Cookson Peirce & Co’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,470	Closed	-$255K	–	176
2016 Q3	$255K	Buy	+8,470	New	+$233K	0.04%	131

Other funds holding SRDX

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cookson Peirce & Co's SRDX Position: Q4 2016 in Review

Cookson Peirce & Co sold out of Surmodics (SRDX) in Q4 2016, closing a stake of 8,470 shares — an estimated $255K sold.

Cookson Peirce & Co first reported a position in SRDX in Q3 2016 and held it in 1 quarter. The position peaked at $255K in Q3 2016. 116 funds tracked by Wall St. Rank hold SRDX as of Q4 2016.

Cookson Peirce & Co reported no remaining Surmodics position as of Q4 2016 after selling out during the quarter.
Cookson Peirce & Co sold 8,470 Surmodics shares in Q4 2016, an estimated $255K.
Cookson Peirce & Co first reported a position in Surmodics in Q3 2016 and held it in 1 quarter.
Cookson Peirce & Co's Surmodics position peaked at $255K in Q3 2016.
116 funds tracked by Wall St. Rank held Surmodics as of Q4 2016.

Based on Cookson Peirce & Co's 13F filing for Q4 2016, filed 7 Feb 2017.